houston eli lilly - Search News

News

Eli Lilly, Big Pharma and compounding

Eli Lilly targets Houston-based Empower Pharmacy over copycat diabetes, weight loss drugs

Eli Lilly suit against Houston’s Empower Pharmacy is a battle over access to a multi-billion dollar market for weight loss drugs tirzepatide and semaglutide.

Houston Public Media · 1d

Eli Lilly sues Houston-based compounding pharmacy over alleged ‘knockoff’ obesity, diabetes drugs

Eli Lilly’s legal actions against Empower Pharmacy and other compounding pharmacies come several months after the FDA announced that a shortage of Mounjaro and Zepbound had been resolved.

The Hill on MSN · 1d

Eli Lilly sues telehealth companies selling compounded Zepbound, Mounjaro

Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its diabetes treatment Mounjaro, escalating its battle against unauthorized

Fierce Pharma20h

Texas outsourcer in Lilly's compounded tirzepatide lawsuit hit with FDA warning letter

A Houston-based compounding pharmacy that was recently roped into Eli Lilly’s fight against knockoff GLP-1s has landed in the FDA’s crosshairs for the second time in less than a year. | The FDA has ...

6don MSN

Eli Lilly says GLP-1 pill for diabetes and weight loss effective in study, plans to seek FDA approval

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

Eli Lilly, Big Pharma and compounding

Trending now